Hypoxia enhances the expression of prostate-specific antigen by modifying the quantity and catalytic activity of Jumonji C domain-containing histone demethylases

Carcinogenesis

Volumn 34, Issue 12, 2013, Pages 2706-2715

  Lee, Ho Youl ^a   Yang, Eun Gyeong ^b   Park, Hyunsung ^a  

^a University of Seoul   (South Korea)

^b Korea Institute of Science and Technology   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; HISTONE ACETYLTRANSFERASE; HISTONE DEMETHYLASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER CELL; CATALYSIS; CELL STRAIN LNCAP; CHROMATIN IMMUNOPRECIPITATION; ENHANCER REGION; HISTONE ACETYLATION; HUMAN; HYPOXIA; OXYGEN CONCENTRATION; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION;

ACETYLATION; ANOXIA; CATALYSIS; CELL LINE, TUMOR; HISTONE ACETYLTRANSFERASES; HISTONES; HUMANS; JUMONJI DOMAIN-CONTAINING HISTONE DEMETHYLASES; KALLIKREINS; MALE; NEOPLASM PROTEINS; NUCLEAR PROTEINS; P300-CBP TRANSCRIPTION FACTORS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; REPRESSOR PROTEINS; UP-REGULATION;

EID: 84888997571     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt256     Document Type: Article

References (44)

1. Semenza,G.L. (2012) Hypoxia-inducible factors in physiology and medicine. Cell, 148, 399-408.
2. Huang,L.E. et al. (1998) Regulation of hypoxia-inducible factor 1a is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc. Natl Acad. Sci. USA, 95, 7987-7992.
3. Bruick,R.K. et al. (2001) A conserved family of prolyl-4-hydroxylases that modify HIF. Science, 294, 1337-1340.
4. Maxwell,P.H. et al. (1999) The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature, 399, 271-275.
5. Chen,Z. et al. (2006) Structural insights into histone demethylation by JMJD2 family members. Cell, 125, 691-702.
6. Whetstine,J.R. et al. (2006) Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases. Cell, 125, 467-481.
7. Shi,Y. et al. (2007) Dynamic regulation of histone lysine methylation by demethylases. Mol. Cell, 25, 1-14.
8. Li,B. et al. (2007) The role of chromatin during transcription. Cell, 128, 707-719.
9. Xia,X. et al. (2009) Integrative analysis of HIF binding and transactivation reveals its role in maintaining histone methylation homeostasis. Proc. Natl Acad. Sci. USA, 106, 4260-4265.
10. Wellmann,S. et al. (2008) Hypoxia upregulates the histone demethylase JMJD1A via HIF-1. Biochem. Biophys. Res. Commun., 372, 892-897.
11. Pollard,P.J. et al. (2008) Regulation of Jumonji-domain-containing histone demethylases by hypoxia-inducible factor (HIF)-1a. Biochem. J., 416, 387-394.
12. Beyer,S. et al. (2008) The histone demethylases JMJD1A and JMJD2B are transcriptional targets of hypoxia-inducible factor HIF. J. Biol. Chem., 283, 36542-36552.
13. Kahl,P. et al. (2006) Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence. Cancer Res., 66, 11341-11347.
14. Shin,S. et al. (2007) Activation of androgen receptor by histone demethylases JMJD2A and JMJD2D. Biochem. Biophys. Res. Commun., 359, 742-746.
15. Wissmann,M. et al. (2007) Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression. Nat. Cell Biol., 9, 347-353.
16. Yamane,K. et al. (2006) JHDM2A, a JmjC-containing H3K9 demethylase, facilitates transcription activation by androgen receptor. Cell, 125, 483-495.
17. Bok,R.A. et al. (2002) Bloodborne biomolecular markers in prostate cancer development and progression. Nat. Rev. Cancer, 2, 918-926.
18. Jia,L. et al. (2006) Locus-wide chromatin remodeling and enhanced androgen receptor-mediated transcription in recurrent prostate tumor cells. Mol. Cell. Biol., 26, 7331-7341.
19. Lee,H.Y. et al. (2011) Src activates HIF-1a not through direct phosphorylation of HIF-1a specific prolyl-4 hydroxylase 2 but through activation of the NADPH oxidase/Rac pathway. Carcinogenesis, 32, 703-712.
20. Metzger,E. et al. (2005) LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription. Nature, 437, 436-439.
21. Cho,H. et al. (2008) Baicalein induces functional hypoxia-inducible factor- 1a and angiogenesis. Mol. Pharmacol., 74, 70-81.
22. Murakami,T. et al. (2007) Identification and characterization of Birt-Hogg- Dubé associated renal carcinoma. J. Pathol., 211, 524-531.
23. Urbanucci,A. et al. (2008) Androgen regulation of the androgen receptor coregulators. BMC Cancer, 8, 219.
24. Zhou,X. et al. (2010) Hypoxia induces trimethylated H3 lysine 4 by inhibition of JARID1A demethylase. Cancer Res., 70, 4214-4221.
25. Park,Y.K. et al. (2010) Prevention of CCAAT/enhancer-binding protein β DNA binding by hypoxia during adipogenesis. J. Biol. Chem., 285, 3289-3299.
26. Kouskouti,A. et al. (2004) Gene-specific modulation of TAF10 function by SET9-mediated methylation. Mol. Cell, 14, 175-182.
27. Woon Kim,Y. et al. (2011) The distinctive roles of erythroid specific activator GATA-1 and NF-E2 in transcription of the human fetal γ-globin genes. Nucleic Acids Res., 39, 6944-6955.
28. Xiang,Y. et al. (2007) JARID1B is a histone H3 lysine 4 demethylase up-regulated in prostate cancer. Proc. Natl Acad. Sci. USA, 104, 19226-19231.
29. Lee,D.Y. et al. (2006) Histone H3 lysine 9 methyltransferase G9a is a transcriptional coactivator for nuclear receptors. J. Biol. Chem., 281, 8476-8485.
30. Pettaway,C.A. et al. (1996) Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice. Clin. Cancer Res., 2, 1627-1636.
31. Horii,K. et al. (2007) Androgen-dependent gene expression of prostatespecific antigen is enhanced synergistically by hypoxia in human prostate cancer cells. Mol. Cancer Res., 5, 383-391.
32. Krieg,A.J. et al. (2010) Regulation of the histone demethylase JMJD1A by hypoxia-inducible factor 1 a enhances hypoxic gene expression and tumor growth. Mol. Cell. Biol., 30, 344-353.
33. Movsas,B. et al. (2001) Hypoxia in human prostate carcinoma: an Eppendorf PO2 study. Am. J. Clin. Oncol., 24, 458-461.
34. Wang,D. et al. (2011) Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA. Nature, 474, 390-394.
35. Sahu,B. et al. (2011) Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer. EMBO J., 30, 3962-3976.
36. Tewari,A.K. et al. (2012) Chromatin accessibility reveals insights into androgen receptor activation and transcriptional specificity. Genome Biol., 13, R88.
37. Lupien,M. et al. (2008) FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription. Cell, 132, 958-970.
38. Chen,H. et al. (2006) Hypoxic stress induces dimethylated histone H3 lysine 9 through histone methyltransferase G9a in mammalian cells. Cancer Res., 66, 9009-9016.
39. Johnson,A.B. et al. (2008) Hypoxia induces a novel signature of chromatin modifications and global repression of transcription. Mutat. Res., 640, 174-179.
40. Metzger,E. et al. (2008) Phosphorylation of histone H3 at threonine 11 establishes a novel chromatin mark for transcriptional regulation. Nat. Cell Biol., 10, 53-60.
41. Thauerer,B. et al. (2010) Vital role of protein kinase C-related kinase in the formation and stability of neurites during hypoxia. J. Neurochem., 113, 432-446.
42. Metzger,E. et al. (2010) Phosphorylation of histone H3T6 by PKCβ(I) controls demethylation at histone H3K4. Nature, 464, 792-796.
43. He,H.H. et al. (2010) Nucleosome dynamics define transcriptional enhancers. Nat. Genet., 42, 343-347.
44. Khandrika,L. et al. (2009) Hypoxia-associated p38 mitogen-activated protein kinase-mediated androgen receptor activation and increased HIF-1a levels contribute to emergence of an aggressive phenotype in prostate cancer. Oncogene, 28, 1248-1260.